Characterizing Glioblastoma Heterogeneity via Single-Cell Receptor Quantification

Dysregulation of tyrosine kinase receptor (RTK) signaling pathways play important roles in glioblastoma (GBM). However, therapies targeting these signaling pathways have not been successful, partially because of drug resistance. Increasing evidence suggests that tumor heterogeneity, more specificall...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Front Bioeng Biotechnol
Main Authors: Chen, Si, Le, Thien, Harley, Brendan A. C., Imoukhuede, P. I.
Formato: Artigo
Idioma:Inglês
Publicado: Frontiers Media S.A. 2018
Assuntos:
Bioengineering and Biotechnology
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6050407/
https://ncbi.nlm.nih.gov/pubmed/30050899
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fbioe.2018.00092
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares